EU - Medicaments Containing Hormones But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingEU: Medicaments Containing Hormones Market 2024
Medicaments Containing Hormones Market Size in the EU
After two years of decline, the EU medicaments containing hormones market increased by X% to $X in 2023. In general, consumption, however, showed a perceptible decline. Over the period under review, the market attained the maximum level at $X in 2012; however, from 2013 to 2023, consumption stood at a somewhat lower figure.
Medicaments Containing Hormones Production in the EU
In value terms, medicaments containing hormones production contracted slightly to $X in 2023 estimated in export price. Over the period under review, production, however, saw a perceptible decline. The most prominent rate of growth was recorded in 2014 with an increase of X% against the previous year. The level of production peaked at $X in 2017; however, from 2018 to 2023, production failed to regain momentum.
Medicaments Containing Hormones Exports
Exports in the EU
In 2023, overseas shipments of medicaments containing hormones but not antibiotics increased by X% to X tons, rising for the fifth year in a row after three years of decline. Over the period under review, exports showed a remarkable increase. The most prominent rate of growth was recorded in 2022 when exports increased by X%. The volume of export peaked in 2023 and is expected to retain growth in the near future.
In value terms, medicaments containing hormones exports surged to $X in 2023. Overall, exports recorded significant growth. The most prominent rate of growth was recorded in 2022 with an increase of X%. The level of export peaked in 2023 and is expected to retain growth in the near future.
Exports by Country
Denmark represented the major exporting country with an export of about X tons, which finished at X% of total exports. Ireland (X tons) held a X% share (based on physical terms) of total exports, which put it in second place, followed by the Netherlands (X%), Spain (X%) and Cyprus (X%). The following exporters - Romania (X tons) and Poland (X tons) - each amounted to an X% share of total exports.
Exports from Denmark increased at an average annual rate of X% from 2012 to 2023. At the same time, Romania (X%), Poland (X%), Spain (X%), Ireland (X%) and the Netherlands (X%) displayed positive paces of growth. Moreover, Romania emerged as the fastest-growing exporter exported in the European Union, with a CAGR of X% from 2012-2023. By contrast, Cyprus (X%) illustrated a downward trend over the same period. While the share of Denmark (X p.p.), Spain (X p.p.), Romania (X p.p.) and Poland (X p.p.) increased significantly in terms of the total exports from 2012-2023, the share of the Netherlands (X p.p.) and Cyprus (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, Ireland ($X) remains the largest medicaments containing hormones supplier in the European Union, comprising X% of total exports. The second position in the ranking was held by Denmark ($X), with a X% share of total exports. It was followed by the Netherlands, with a X% share.
In Ireland, medicaments containing hormones exports expanded at an average annual rate of X% over the period from 2012-2023. In the other countries, the average annual rates were as follows: Denmark (X% per year) and the Netherlands (X% per year).
Export Prices by Country
In 2023, the export price in the European Union amounted to $X per ton, picking up by X% against the previous year. In general, the export price saw a buoyant increase. The growth pace was the most rapid in 2022 an increase of X% against the previous year. The level of export peaked in 2023 and is expected to retain growth in the immediate term.
Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Ireland ($X,927 per ton), while Cyprus ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Ireland (X%), while the other leaders experienced mixed trends in the export price figures.
Medicaments Containing Hormones Imports
Imports in the EU
In 2023, the amount of medicaments containing hormones but not antibiotics imported in the European Union soared to X tons, with an increase of X% against the previous year's figure. Total imports indicated a strong increase from 2012 to 2023: its volume increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, imports increased by X% against 2012 indices. As a result, imports attained the peak and are likely to continue growth in the immediate term.
In value terms, medicaments containing hormones imports soared to $X in 2023. Over the period under review, imports recorded buoyant growth. The growth pace was the most rapid in 2020 with an increase of X%. As a result, imports reached the peak of $X. From 2021 to 2023, the growth of imports remained at a somewhat lower figure.
Imports by Country
The countries with the highest levels of medicaments containing hormones imports in 2023 were the Netherlands (X tons), France (X tons), Spain (X tons) and Denmark (X tons), together amounting to X% of total import. It was distantly followed by Poland (X tons), Bulgaria (X tons) and Ireland (X tons), together committing an X% share of total imports.
From 2012 to 2023, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by Bulgaria (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.
In value terms, the largest medicaments containing hormones importing markets in the European Union were Denmark ($X), the Netherlands ($X) and Ireland ($X), together comprising X% of total imports. Poland, Bulgaria, France and Spain lagged somewhat behind, together accounting for a further X%.
In terms of the main importing countries, Bulgaria, with a CAGR of X%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
In 2023, the import price in the European Union amounted to $X per ton, with an increase of X% against the previous year. In general, the import price showed a perceptible expansion. The growth pace was the most rapid in 2020 an increase of X%. As a result, import price attained the peak level of $X per ton. From 2021 to 2023, the import prices remained at a somewhat lower figure.
There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was Ireland ($X per ton), while Spain ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Bulgaria (X%), while the other leaders experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the medicaments containing hormones market in the EU. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201250 - Medicaments containing hormones but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale (excluding insulin)
Country coverage:
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Latvia
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in the EU, split by region and country
- Trade (exports and imports) in the EU
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Ireland
- Italy
- Latvia
- Lithuania
- Luxembourg
- Malta
- Netherlands
- Poland
- Portugal
- Romania
- Slovakia
- Slovenia
- Spain
- Sweden
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the medicaments containing hormones market in Asia.
This report provides an in-depth analysis of the medicaments containing hormones market in the U.S..
This report provides an in-depth analysis of the medicaments containing hormones market in China.
This report provides an in-depth analysis of the global medicaments containing hormones market.